S100A8 and systemic sclerosis: The addition of huDNA to SSc plasma, and not to HD plasma, significantly increased IFN-α production (Fig. 7a), an effect blocked by anti-CXCL43, but not by control anti-S100A8 antibodies (Fig. 7b).